
The global Genome Chip market size is predicted to grow from US$ 899 million in 2025 to US$ 989 million in 2031; it is expected to grow at a CAGR of 1.6% from 2025 to 2031.
Genome-wide analysis of ChIP-isolated DNA, either by microarray hybridization (ChIP-chip) or by sequencing (ChIP-seq), reveals how regulatory and structural proteins bind and interact across a genome. ChIP-chip can be performed using promoter or genomic tiling arrays.
Following a strong growth of 26.2 percent in the year 2021, WSTS revised it down to a single digit growth for the worldwide semiconductor market in 2022 with a total size of US$580 billion, up 4.4 percent. WSTS lowered growth estimation as inflation rises and end markets seeing weaker demand, especially those exposed to consumer spending. While some major categories are still double-digit year-over-year growth in 2022, led by Analog with 20.8 percent, Sensors with 16.3 percent, and Logic with 14.5 percent growth. Memory declined with 12.6 percent year over year. In 2022, all geographical regions showed double-digit growth except Asia Pacific. The largest region, Asia Pacific, declined 2.0 percent. Sales in the Americas were US$142.1 billion, up 17.0% year-on-year, sales in Europe were US$53.8 billion, up 12.6% year-on-year, and sales in Japan were US$48.1 billion, up 10.0% year-on-year. However, sales in the largest Asia-Pacific region were US$336.2 billion, down 2.0% year-on-year.
publisher, Inc. (LPI) ' newest research report, the “Genome Chip Industry Forecast” looks at past sales and reviews total world Genome Chip sales in 2024, providing a comprehensive analysis by region and market sector of projected Genome Chip sales for 2025 through 2031. With Genome Chip sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genome Chip industry.
This Insight Report provides a comprehensive analysis of the global Genome Chip landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Genome Chip portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Genome Chip market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genome Chip and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genome Chip.
This report presents a comprehensive overview, market shares, and growth opportunities of Genome Chip market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Oligonucleotide DNA Chip
Complementary DNA Chip
Segmentation by Application:
Research Centers
Clinical
Commercial Molecular Diagnostic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Illumnia
Affymetrix
Agilent
Scienion AG
Applied Microarrays
Arrayit
Sengenics
Biometrix Technology
Savyon Diagnostics
WaferGen
Key Questions Addressed in this Report
What is the 10-year outlook for the global Genome Chip market?
What factors are driving Genome Chip market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Genome Chip market opportunities vary by end market size?
How does Genome Chip break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Genome Chip Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Genome Chip by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Genome Chip by Country/Region, 2020, 2024 & 2031
2.2 Genome Chip Segment by Type
2.2.1 Oligonucleotide DNA Chip
2.2.2 Complementary DNA Chip
2.3 Genome Chip Sales by Type
2.3.1 Global Genome Chip Sales Market Share by Type (2020-2025)
2.3.2 Global Genome Chip Revenue and Market Share by Type (2020-2025)
2.3.3 Global Genome Chip Sale Price by Type (2020-2025)
2.4 Genome Chip Segment by Application
2.4.1 Research Centers
2.4.2 Clinical
2.4.3 Commercial Molecular Diagnostic
2.4.4 Others
2.5 Genome Chip Sales by Application
2.5.1 Global Genome Chip Sale Market Share by Application (2020-2025)
2.5.2 Global Genome Chip Revenue and Market Share by Application (2020-2025)
2.5.3 Global Genome Chip Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Genome Chip Breakdown Data by Company
3.1.1 Global Genome Chip Annual Sales by Company (2020-2025)
3.1.2 Global Genome Chip Sales Market Share by Company (2020-2025)
3.2 Global Genome Chip Annual Revenue by Company (2020-2025)
3.2.1 Global Genome Chip Revenue by Company (2020-2025)
3.2.2 Global Genome Chip Revenue Market Share by Company (2020-2025)
3.3 Global Genome Chip Sale Price by Company
3.4 Key Manufacturers Genome Chip Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Genome Chip Product Location Distribution
3.4.2 Players Genome Chip Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Genome Chip by Geographic Region
4.1 World Historic Genome Chip Market Size by Geographic Region (2020-2025)
4.1.1 Global Genome Chip Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Genome Chip Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Genome Chip Market Size by Country/Region (2020-2025)
4.2.1 Global Genome Chip Annual Sales by Country/Region (2020-2025)
4.2.2 Global Genome Chip Annual Revenue by Country/Region (2020-2025)
4.3 Americas Genome Chip Sales Growth
4.4 APAC Genome Chip Sales Growth
4.5 Europe Genome Chip Sales Growth
4.6 Middle East & Africa Genome Chip Sales Growth
5 Americas
5.1 Americas Genome Chip Sales by Country
5.1.1 Americas Genome Chip Sales by Country (2020-2025)
5.1.2 Americas Genome Chip Revenue by Country (2020-2025)
5.2 Americas Genome Chip Sales by Type (2020-2025)
5.3 Americas Genome Chip Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Genome Chip Sales by Region
6.1.1 APAC Genome Chip Sales by Region (2020-2025)
6.1.2 APAC Genome Chip Revenue by Region (2020-2025)
6.2 APAC Genome Chip Sales by Type (2020-2025)
6.3 APAC Genome Chip Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Genome Chip by Country
7.1.1 Europe Genome Chip Sales by Country (2020-2025)
7.1.2 Europe Genome Chip Revenue by Country (2020-2025)
7.2 Europe Genome Chip Sales by Type (2020-2025)
7.3 Europe Genome Chip Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Genome Chip by Country
8.1.1 Middle East & Africa Genome Chip Sales by Country (2020-2025)
8.1.2 Middle East & Africa Genome Chip Revenue by Country (2020-2025)
8.2 Middle East & Africa Genome Chip Sales by Type (2020-2025)
8.3 Middle East & Africa Genome Chip Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Genome Chip
10.3 Manufacturing Process Analysis of Genome Chip
10.4 Industry Chain Structure of Genome Chip
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Genome Chip Distributors
11.3 Genome Chip Customer
12 World Forecast Review for Genome Chip by Geographic Region
12.1 Global Genome Chip Market Size Forecast by Region
12.1.1 Global Genome Chip Forecast by Region (2026-2031)
12.1.2 Global Genome Chip Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Genome Chip Forecast by Type (2026-2031)
12.7 Global Genome Chip Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Illumnia
13.1.1 Illumnia Company Information
13.1.2 Illumnia Genome Chip Product Portfolios and Specifications
13.1.3 Illumnia Genome Chip Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Illumnia Main Business Overview
13.1.5 Illumnia Latest Developments
13.2 Affymetrix
13.2.1 Affymetrix Company Information
13.2.2 Affymetrix Genome Chip Product Portfolios and Specifications
13.2.3 Affymetrix Genome Chip Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Affymetrix Main Business Overview
13.2.5 Affymetrix Latest Developments
13.3 Agilent
13.3.1 Agilent Company Information
13.3.2 Agilent Genome Chip Product Portfolios and Specifications
13.3.3 Agilent Genome Chip Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Agilent Main Business Overview
13.3.5 Agilent Latest Developments
13.4 Scienion AG
13.4.1 Scienion AG Company Information
13.4.2 Scienion AG Genome Chip Product Portfolios and Specifications
13.4.3 Scienion AG Genome Chip Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Scienion AG Main Business Overview
13.4.5 Scienion AG Latest Developments
13.5 Applied Microarrays
13.5.1 Applied Microarrays Company Information
13.5.2 Applied Microarrays Genome Chip Product Portfolios and Specifications
13.5.3 Applied Microarrays Genome Chip Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Applied Microarrays Main Business Overview
13.5.5 Applied Microarrays Latest Developments
13.6 Arrayit
13.6.1 Arrayit Company Information
13.6.2 Arrayit Genome Chip Product Portfolios and Specifications
13.6.3 Arrayit Genome Chip Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Arrayit Main Business Overview
13.6.5 Arrayit Latest Developments
13.7 Sengenics
13.7.1 Sengenics Company Information
13.7.2 Sengenics Genome Chip Product Portfolios and Specifications
13.7.3 Sengenics Genome Chip Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Sengenics Main Business Overview
13.7.5 Sengenics Latest Developments
13.8 Biometrix Technology
13.8.1 Biometrix Technology Company Information
13.8.2 Biometrix Technology Genome Chip Product Portfolios and Specifications
13.8.3 Biometrix Technology Genome Chip Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Biometrix Technology Main Business Overview
13.8.5 Biometrix Technology Latest Developments
13.9 Savyon Diagnostics
13.9.1 Savyon Diagnostics Company Information
13.9.2 Savyon Diagnostics Genome Chip Product Portfolios and Specifications
13.9.3 Savyon Diagnostics Genome Chip Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Savyon Diagnostics Main Business Overview
13.9.5 Savyon Diagnostics Latest Developments
13.10 WaferGen
13.10.1 WaferGen Company Information
13.10.2 WaferGen Genome Chip Product Portfolios and Specifications
13.10.3 WaferGen Genome Chip Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 WaferGen Main Business Overview
13.10.5 WaferGen Latest Developments
14 Research Findings and Conclusion
*If Applicable.
